2023 annual financial data
LENZ Therapeutics 2023 Net income growth
Direct answer
Net income growth was -547.19%.
Operating income was -72,429,000 USD and net income was -69,968,000 USD.
Operating cash flow was -60,380,000 USD.
Get free LENZ Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -72,429,000 USD
- Net income
- -69,968,000 USD
- Operating cash flow
- -60,380,000 USD